Network Meta-Analysis of the Efficacy of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Versus Other Triple Therapies for the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comparison of Annual Moderate and Severe Exacerbations

被引：0
|
作者：
Ismaila, A. S. [1 ]
Haeussler, K. [2 ]
Czira, A. [3 ]
Youn, J. [4 ]
Malmenas, M. [5 ]
Risebrough, N. [6 ]
Agarwal, J. [7 ]
Nassim, M.
Sharma, R. [3 ]
Compton, C. [3 ]
Vogelmeier, C. F. [8 ]
Halpin, D. M. G. [9 ]
机构：
[1] GlaxoSmithKline, R&D Global Med, Collegeville, PA USA
[2] ICON plc, Munich, Germany
[3] GlaxoSmithKline, R&D Global Med, Brentford, England
[4] ICON plc, London, England
[5] ICON plc, Stockholm, Sweden
[6] ICON plc, Burlington, ON, Canada
[7] ICON plc, Bangalore, Karnataka, India
[8] Philipps Univ Marburg, Univ Med Ctr Giessen & Marburg, Dept Med, Pulm & Crit Care Med, Marburg, Germany
[9] Univ Exeter, Univ Exeter Med Sch, Coll Med & Hlth, Exeter, Devon, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1454
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis (Jul, 10.1007/s12325-022-02234-x, 2022)
    Ismaila, Afisi S.
    Haeussler, Katrin
    Czira, Alexandrosz
    Tongbram, Vanita
    Malmenas, Mia
    Agarwal, Jatin
    Nassim, Maria
    Zivkovic-Gojovic, Marija
    Shen, Yunrong
    Dong, Xinzhe
    Duarte, Maria
    Compton, Chris
    Vogelmeier, Claus F.
    Halpin, David M. G.
    ADVANCES IN THERAPY, 2022, 39 (11) : 5011 - 5012
  • [32] Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England
    Requena, Gema
    Czira, Alexandrosz
    Banks, Victoria
    Wood, Robert
    Tritton, Theo
    Castillo, Catherine
    Yeap, Jie
    Wild, Rosie
    Compton, Chris
    Rothnie, Kieran J.
    Herth, Felix J. F.
    Quint, Jennifer K.
    Ismaila, Afisi S.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 2039 - 2054
  • [33] UMECLIDINIUM/VILANTEROL (UMEC/VI) VERSUS MONO-BRONCHODILATOR THERAPY IN STEROID-FREE GOLD B PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): THE EMAX TRIAL
    Jones, P. W.
    Maltais, F.
    Kerwin, E.
    Bjermer, L.
    Watkins, M. L.
    Tombs, L.
    Naya, I.
    Boucot, I.
    Lipson, D.
    Compton, C.
    THORAX, 2018, 73 : A235 - A236
  • [34] Comparative Efficacy Of Umeclidinium/vilanterol Versus Other Lama/laba As Maintenance Treatments For COPD: A Systematic Review And Network Meta-Analysis
    Ismaila, A. S.
    Huisman, E.
    Punekar, Y. S.
    Karabis, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [35] Single-Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Improves Lung Function and Symptoms Compared with Tiotropium Monotherapy in Patients with Symptomatic Chronic Obstructive Pulmonary Disease at Risk of Exacerbations
    Obeid, D.
    Bansal, S.
    Brown, N.
    Compton, C.
    Corbridge, T. C.
    Dorais, K.
    Erb, D.
    Harvey, C.
    Kaisermann, M. C.
    Kaye, M.
    Lipson, D. A.
    Martin, N.
    Zhu, C. Q.
    Papi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [36] Safety and efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in moderate-to-severe chronic obstructive pulmonary disease: A systematic review and meta-analysis
    Maya, T.
    Mathew, Alisha
    Raj, Elstin Anbu S.
    Vilakkathala, Rajesh
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 395 - 396
  • [37] THE IMPACT TRIAL: COST-EFFECTIVENESS ANALYSIS OF SINGLE-INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS DUAL BRONCHODILATOR THERAPY (UMEC/VI) IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SPAIN
    Vallejo-Aparicio, L. A.
    Paly, V. F.
    Schroeder, M.
    Martin, A.
    Risebrough, N.
    Abreu, C.
    Biswas, C.
    Izquierdo Alonso, J. L.
    Riesco Miranda, J. A.
    Soler Cataluna, J. J.
    Ismaila, A. S.
    VALUE IN HEALTH, 2019, 22 : S878 - S878
  • [38] An Investigation on the Effects of Prompt Versus Delayed Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol Single-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in the United States
    Noorduyn, S.
    Mannino, D.
    Dirocco, K.
    Germain, G.
    Laliberte, F.
    Urosevic, A.
    Paczkowski, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [39] Comparative Efficacy of Budesonide/Formoterol Versus Fluticasone/Salmeterol in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
    Shang, Nan
    Liu, Yang
    Jin, Yueping
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 21 (01)
  • [40] Effect of Recent Exacerbation History on the Efficacy of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease in the FULFIL Trial
    Panettieri, Reynold A., Jr.
    Camargo, Carlos A., Jr.
    Cheema, Tariq
    Bayadi, Sherif G. El
    Fiel, Stanley
    Vila, Tania M.
    Jain, Renu G.
    Midwinter, Dawn
    Thomashow, Byron
    Ludwig-Sengpiel, Andrea
    Lipson, David A.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 2043 - 2052
12345